These results could prompt more research exploring the therapeutic benefits of psilocybin and how it could foster adaptive behavior. In addition, future work could examine the neural mechanisms ...

Chronic pain affects more than 1.5 billion people worldwide and is often deeply entangled with depression and anxiety, creating a vicious cycle that amplifies suffering and impairs quality of life. A ...

For veterans with severe post-traumatic stress disorder (PTSD), finding a treatment that works can be a challenge. An option which has gained acceptance in recent years is psychedelic-assisted therapy ...

As psychedelic-assisted therapy grows in popularity, several substances are being recognized for their potential in treating trauma. Psilocybin, ketamine, and MDMA have emerged as some of the most ...

LONDON, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today ...

ITHACA, N.Y. – Psilocybin is the active ingredient that gives so-called “magic mushrooms” their hallucinogenic kick. It also has a therapeutic potential for treating depression. Now, Cornell ...

In a recent study published in the journal Scientific Reports, a group of researchers investigated whether psilocybin acutely and in the long term reduces confidence in negative self-beliefs and how ...

“The positive top-line results at week 6 from the COMP005 trial underscore the innovative potential of psilocybin treatment in mental health care for which Compass Pathways continues to pave the way,” ...

"However, its impact on the neural activity underlying sustained changes in behavioral flexibility has not been characterized. To test whether psilocybin enhances behavioral flexibility by altering ...

Open-label Phase 2 study shows a single 25 mg COMP360 psilocybin dose was well tolerated, with no serious adverse events observed, and indicated both rapid and durable improvement in symptoms from ...